315 related articles for article (PubMed ID: 19682779)
21. Birth weight and stages of CKD: a case-control study in an Australian population.
Al Salmi I; Hoy WE; Kondalsamy-Chennakes S; Wang Z; Healy H; Shaw JE
Am J Kidney Dis; 2008 Dec; 52(6):1070-8. PubMed ID: 18640755
[TBL] [Abstract][Full Text] [Related]
22. Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden.
Evans M; Fored CM; Nise G; Bellocco R; Nyrén O; Elinder CG
Am J Kidney Dis; 2010 Mar; 55(3):497-506. PubMed ID: 20116912
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
[TBL] [Abstract][Full Text] [Related]
24. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress is progressively enhanced with advancing stages of CKD.
Dounousi E; Papavasiliou E; Makedou A; Ioannou K; Katopodis KP; Tselepis A; Siamopoulos KC; Tsakiris D
Am J Kidney Dis; 2006 Nov; 48(5):752-60. PubMed ID: 17059994
[TBL] [Abstract][Full Text] [Related]
28. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
29. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
30. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
31. Comparison of arsenic levels in fingernails with urinary As species as biomarkers of arsenic exposure in residents living close to a coal-burning power plant in Prievidza District, Slovakia.
Wilhelm M; Pesch B; Wittsiepe J; Jakubis P; Miskovic P; Keegan T; Nieuwenhuijsen MJ; Ranft U
J Expo Anal Environ Epidemiol; 2005 Jan; 15(1):89-98. PubMed ID: 15026779
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer.
Chung CJ; Hsueh YM; Bai CH; Huang YK; Huang YL; Yang MH; Chen CJ
Cancer Causes Control; 2009 Nov; 20(9):1653-61. PubMed ID: 19680750
[TBL] [Abstract][Full Text] [Related]
33. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective.
Tseng CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):1-22. PubMed ID: 17365340
[TBL] [Abstract][Full Text] [Related]
34. Arsenic methylation capacity and developmental delay in preschool children in Taiwan.
Hsieh RL; Huang YL; Shiue HS; Huang SR; Lin MI; Mu SC; Chung CJ; Hsueh YM
Int J Hyg Environ Health; 2014 Jul; 217(6):678-86. PubMed ID: 24698386
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
36. Arsenic methylation capacity and skin cancer.
Yu RC; Hsu KH; Chen CJ; Froines JR
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1259-62. PubMed ID: 11097236
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors.
Safarinejad MR
J Nephrol; 2009; 22(1):99-108. PubMed ID: 19229824
[TBL] [Abstract][Full Text] [Related]
38. Plasma Vitamin B
Hsueh YM; Huang YL; Lin YF; Shiue HS; Lin YC; Chen HH
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836097
[TBL] [Abstract][Full Text] [Related]
39. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
Bello AK; Peters J; Wight J; de Zeeuw D; El Nahas M;
Am J Kidney Dis; 2008 Sep; 52(3):434-43. PubMed ID: 18725014
[TBL] [Abstract][Full Text] [Related]
40. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan.
Guh JY; Chen HC; Tsai JF; Chuang LY
Am J Kidney Dis; 2007 May; 49(5):626-33. PubMed ID: 17472844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
